Mapping the Way: Opportunities in Diagnostics

29 September 2010 Past Event

In an era of health reform, diagnostic technologies that focus on prevention and test the viability of expensive treatment options are becoming increasingly valuable to health providers, payers, and patients. Historically, investment in this sector has not seen the vigor demonstrated with medical devices or biotech innovations. However, in today's environment, diagnostics are becoming attractive opportunities for companies looking for collaborations or acquisitions as well as investors looking for cutting-edge technologies, all creating a robust industry on the brink of breaking through to the mainstream.

In this presentation, panelists will:

  • Provide insight on the diagnostic industry on a local and national level
  • Discuss key elements that are reviewed when assessing start-up opportunities
  • Discuss where opportunities exist for maximizing profits
  • Provide new strategies for raising funds in this dynamic marketplace

Panelists:

  • Stephen DiPalma, Chief Financial Officer, Envivo Pharmaceuticals
  • Ronald S. Eppen, Partner, Foley & Lardner LLP
  • Mitchell Sanders, CEO and Founder, ECI Biotech

Insights

Seventh Circuit Confronts Wisconsin’s “Risk-Contribution” Theory in Reversing $6 Million Lead Paint Verdict
06 May 2021
Wisconsin Appellate Law
It is Not Just Auto, Supply Chains are Stressed
06 May 2021
Dashboard Insights
DOL Rolls Back Trump Administration’s Independent Contractor Rule
05 May 2021
Labor & Employment Law Perspectives
190 Across the Finish Line: CFTC Adopts New Bankruptcy Rules for FCMS and DCOS
05 May 2021
The Journal on the Law of Investment & Risk Management Products, Futures & Derivatives Law Report
Home Care 100
27-30 June 2021
Marco Island, FL
2021 AANP National Conference
15 June - 31 August 2021
Virtual Conference
HCCA Orange County Regional Healthcare Compliance Conference
11 June 2021
Virtual Conference
Rx Pricing and Reimbursement Summit
24-25 May 2021
Virtual Conference